Conceptual Framework: The Tetra-Shield Protocol for Arterial Rehabilitation and Prevention of Cardiovascular Events

Background: Cardiovascular disease remains the leading global cause of mortality, with atherosclerosis as the primary pathological substrate. Current therapeutic modalities address individual risk factors but do not fully account for the integrated neuro-mechanical-biochemical milieu of arterial degeneration.Objective: This conceptual, computational paper presents the Tetra-Shield protocol, a four-pillar integrative framework — neuromuscular modulation, targeted nanotherapy, hemodynamic optimization, and AI-driven biosensing — addressing the multifactorial pathophysiology of atherosclerosis through a systems biology perspective, with mathematical models verified in closed form and cross-validated across independent computational methods.Methods: Mathematical models are derived from biophysical first principles (a damped-harmonic-oscillator reduction for vasospasm, reaction kinetics for plaque evolution, Poiseuille's law for hemodynamics, Bayesian updating for risk inference). Closed-form analytic solutions are derived for the Pillar 1 and Pillar 2 governing equations and verified against numerical integration to a maximum discrepancy below 10^-9 mm, certifying the numerical solver independently of any single simulation run. Global sensitivity is assessed by Sobol indices (Saltelli sampling, n=1024) and by Morris elementary-effects screening implemented in the normalized unit hypercube (validated against a linear test function with an analytically known elementary effect), with Monte Carlo uncertainty quantification (N=10,000). Pillar 2's statistical comparison uses conjugate Bayesian updating together with an independent two-sample t-test computed from a single execution so that the reported t-statistic and p-value are guaranteed mutually consistent. Pillar 4 uses a histogram-based gradient-boosted classifier (HistGradientBoostingClassifier) trained on three mechanistic features obtained directly from the Pillar 1 to 3 equations, with permutation importance for interpretability. A physics-informed neural network, implemented with a hard boundary-constraint ansatz and exact analytic differentiation, solves the reduced-order steady Hagen-Poiseuille boundary value problem and is used as an independent, spatially resolved cross-validation of the Pillar 3 algebraic wall shear stress formula. Credibility is assessed per ASME V&V 40 standards.Results: The closed-form and numerical solutions for Pillars 1 and 2 agree to within 10^-9 mm. Under persistent sinusoidal forcing, vessel radius dynamics converge to a forced periodic limit cycle of amplitude 0.249 mm around the equilibrium radius alpha equal to 0.8 mm; plaque fibrous cap thickness approaches an asymptotic 1.5 mm, reaching 1.132 mm at day 10; wall shear stress follows the predicted inverse-cubic relationship with vessel radius (tau equal to 3.183 Pa at nominal r equal to 2 mm), independently reproduced by the physics-informed neural network to a relative error of 1.3×10^-12 percent. Sobol analyses identify a single dominant parameter per pillar (T: S1 equal to 0.7615 in Pillar 1; hmax: S1 equal to 0.5587 in Pillar 2; r: S1 equal to 0.8061 in Pillar 3), independently confirmed by Morris screening, which additionally establishes that hmax's effect on Pillar 2 is exactly linear with negligible interaction variance. The Pillar 4 classifier, trained on mechanistically derived features, achieves AUC equal to 0.819 (95% CI [0.758, 0.870]; 5-fold cross-validated AUC equal to 0.809 ± 0.021). Under idealized in silico conditions (all pillars at nominal capacity, no inter-pillar interference), the coupled system generates a hypothetical mortality-reduction estimate of 45 to 65 percent (95% CrI: 40 to 70 percent, mean 54 percent).Limitations: All outcomes are computational. Parameter distributions are assumed uniform for computational convenience. The classifier is trained on synthetic, mechanistically generated data rather than clinical measurements. Inter-pillar coupling is modeled but not empirically validated, and the hypothetical mortality-reduction estimate is bounded chiefly by the independence and additivity assumptions underlying its construction rather than by the numerical precision of any individual pillar. A full three-dimensional, unsteady extension of the physics-informed neural network is proposed as future work and is not itself a validated result of this study.Conclusions: The Tetra-Shield framework demonstrates internal consistency, closed-form verifiability, and concordant multi-method sensitivity and cross-validation results as a computational proof-of-concept. The reported quantitative projections describe model behavior under defined assumptions and do not constitute clinical efficacy evidence. Prospective empirical validation through preclinical studies and randomized controlled trials is required before any translational inference can be drawn.